The decision to suspend the trial is viewed as highly questionable, raising disturbing questions about the role that marketing played–especially in light of the fact that Zytiga’s patent is due to expire in 2017.
“Overuse is one of the most serious crises in American medicine.” The crisis is not only of misspending of resources, overuse of medical treatments is causing treatment-produced harm, including preventable deaths.
America’s health care expenditure is about to go through the roof–without improving anyone’s health! Continue reading →
New York Times reporter Gina Kolata, broadcasts medical hype on the front page of the paper much the way Judith Miller broadcast hype fed to her by Ahmed Chalabi and the Iraq war lobby. Continue reading →
Unlike patients in other fields of medicine, those who are designated mentally ill–or even declared to be "at risk" for mental illness in the future–are at once stigmatized and suffer losss of their autonomy.
Continue reading →
…instead of informed patient consent, doctors too often promoted trial treatments as superior to standard approaches, even when there was no supporting evidence.
America’s profit-driven medical paradigm overdiagnoses illness and garners profits from unnecessary treatment. Continue reading →
"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." Marcia Angell, MD Continue reading →
The LAT reports that the Center for Evaluation of Risks to Human Reproduction has been outsourcing the writing of its "scientific" reports to an industry consulting firm, Sciences International.
Continue reading →
Just How Effective are Medical Screening Tests? Mon, 17 Nov 2003 A investigative report in the Guardian (UK) takes a critical view of medical screening for early detection of latent diseases. Contrary to the promoters of medical screening tests, there is scant . . . Continue reading →
AstraZeneca Pleads Guilty in Criminal Cancer Medicine Scheme Sun, 22 Jun 2003 AstraZeneca agreed to a $355 million settlement in civil and criminal charges. Government prosecutors found that AstraZeneca reported to the government that the average wholesale price for a monthly dose . . . Continue reading →
The Crawford Resignation Mystery Sat, 24 Sep 2005 Merrill Goozner of Center for Science in the Public Interest provides insight into what may lie behind the sudden resignation of FDA Commissioner, Lester Crawford. Goozner surggests, “One possible clue to the administration’s thinking . . . Continue reading →